FALON KUHN: Open Payments
NPI 1215596770 · SYRACUSE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$752 in 40 payments from 16 companies in 2025. Trend: 2023 $436 · 2024 $691 · 2025 $752
Food & beverage: $713Education: $39
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $157 |
| AstraZeneca Pharmaceuticals LP | 7 | $131 |
| Vanda Pharmaceuticals Inc. | 3 | $99 |
| Novo Nordisk Inc | 3 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Exact Sciences Corporation | 2 | $31 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Inspire Medical Systems, Inc. | 1 | $28 |
| Lilly USA, LLC | 1 | $22 |
Products named: VRAYLAR, FANAPT, JARDIANCE, BREZTRI, Kerendia, FARXIGA, Wegovy, REXULTI.
Industry payments across IN — which companies pay providers there.
